A Phase 2, Multicenter, Randomized, Double-blind, Placebo- and Active-controlled Trial of Brexpiprazole as Monotherapy or as Combination Therapy in the Treatment of Adults With Post-traumatic Stress Disorder
Phase of Trial: Phase II
Latest Information Update: 09 Jan 2019
At a glance
- Drugs Brexpiprazole (Primary) ; Sertraline
- Indications Post-traumatic stress disorders
- Focus Therapeutic Use
- Sponsors Otsuka Pharmaceutical Development & Commercialization
- 03 Jan 2019 Status changed from active, no longer recruiting to completed.
- 30 Nov 2018 Results presented in the Lundbeck A/S media release.
- 30 Nov 2018 According to a Lundbeck A/S media release, the company plans to meet with the U.S. Food and Drug Administration (FDA) to discuss the results of this trial and to evaluate continuation of the program.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History